Light Mode
$0.0002 ↑ +0.0001 (+100.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0002
+0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
ARDS reads n/a: price sits above one of the two key moving averages, the 12-month move is -89.5%.
No alerts for ARDS in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.